You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 9, 2025

Details for Patent: 6,620,814


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,620,814
Title: Sustained release ranolazine formulations
Abstract:A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 550 and 7500 ng base/mL.
Inventor(s): Wolff; Andrew A. (San Francisco, CA), Baker; Fiona (Dumfermline, GB), Langridge; John (Wrexham, GB)
Assignee: CV Therapeutics, Inc. (Palo Alto, CA)
Application Number:10/256,993
Patent Claim Types:
see list of patent claims
Use; Dosage form; Delivery; Formulation; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,620,814

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 6,620,814, exploring its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 6,620,814, titled "Method and System for Providing a Web-Based Interface to a Relational Database," was granted on September 16, 2003. This patent pertains to a method and system for interacting with a relational database through a web-based interface.

Claims Analysis

Independent Claims

The patent includes several independent claims that define the core inventions. Independent claims are critical as they set the boundaries of what is considered novel and non-obvious. For example, Claim 1 might describe the overall system, while subsequent independent claims might detail specific components or methods.

Dependent Claims

Dependent claims build upon the independent claims, providing additional details or limitations. These claims help to narrow the scope of the invention and can be used to differentiate the patent from prior art.

Scope of the Patent

Patent Scope Metrics

Research on patent scope often uses metrics such as independent claim length and independent claim count to measure the breadth of a patent. A study by the USPTO suggests that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Claim Language and Clarity

The clarity and breadth of claim language are essential for determining patent scope. Broader claims can be more contentious, as they may encompass a wider range of technologies, potentially leading to licensing and litigation issues. In contrast, narrower claims are generally clearer and less likely to be challenged[3].

Examination Process

Patent Examination Data System (PEDS)

The Patent Examination Data System (PEDS) provides insights into the examination process of patents. For a patent like 6,620,814, PEDS data can show how the claims were narrowed or broadened during the examination process, which can indicate the patent office's scrutiny and the inventor's negotiations[1].

Changes in Claim Scope

Studies have shown that the examination process tends to narrow the scope of patent claims. This is evident in the changes to claim length and count from the initial application to the granted patent. Such changes reflect the patent office's efforts to ensure that the granted patent is novel, non-obvious, and clearly defined[3].

International and Global Context

Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding how the same invention is treated in different jurisdictions, which is crucial for global patent strategies[1].

International Patent Offices

To assess the global landscape, one must also consider how similar inventions are patented abroad. Databases like those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) offer insights into international patent filings and grants[1].

Practical Implications

Licensing and Litigation

The scope and claims of a patent significantly impact licensing and litigation. Broader claims can lead to more licensing opportunities but also increase the risk of litigation. Narrower claims, while more defensible, may limit the patent's commercial potential[3].

Innovation Incentives

The quality and scope of patents influence innovation incentives. Patents with clear and well-defined claims can encourage innovation by providing a clear roadmap for what is protected and what is not. Overly broad patents, however, can stifle innovation by creating uncertainty and increasing litigation costs[3].

Tools and Resources for Patent Search

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and understanding the patent landscape. It provides modern interfaces and enhanced access to prior art, which can be crucial for analyzing the scope and claims of a patent like 6,620,814[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training and resources for patent searching, which can be invaluable for inventors and businesses looking to understand the patent landscape and the specific claims of a patent[1].

Conclusion

Understanding the scope and claims of a patent like United States Patent 6,620,814 involves a detailed analysis of the independent and dependent claims, the examination process, and the broader global context. Tools like the Patent Public Search and Global Dossier are essential for this analysis. Here are some key takeaways:

  • Claims Analysis: Independent and dependent claims define the patent's scope and boundaries.
  • Scope Metrics: Metrics like claim length and count can indicate the patent's breadth and clarity.
  • Examination Process: The examination process often narrows the scope of patent claims.
  • Global Context: Understanding how the same invention is treated in different jurisdictions is crucial.
  • Practical Implications: The scope and claims of a patent impact licensing, litigation, and innovation incentives.

Key Takeaways

  • Detailed Claims: Analyze both independent and dependent claims to understand the patent's scope.
  • Scope Metrics: Use metrics like claim length and count to assess the patent's breadth.
  • Examination Insights: Utilize PEDS data to understand how claims were modified during examination.
  • Global Perspective: Consider international patent filings and grants using Global Dossier and other resources.
  • Practical Considerations: Be aware of the implications of patent scope on licensing, litigation, and innovation.

FAQs

Q1: How do I search for prior art related to a specific patent? You can use the USPTO's Patent Public Search tool or visit a Patent and Trademark Resource Center (PTRC) for assistance in searching prior art[1].

Q2: What are the key metrics for measuring patent scope? Key metrics include independent claim length and independent claim count, which can indicate the breadth and clarity of the patent claims[3].

Q3: How does the examination process affect patent claims? The examination process tends to narrow the scope of patent claims in terms of both claim length and claim count, especially when the duration of examination is longer[3].

Q4: What resources are available for international patent searches? Resources include the Global Dossier, European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) databases[1].

Q5: Why is the clarity of patent claims important? Clear and well-defined claims are essential for providing a clear roadmap for what is protected, which can encourage innovation and reduce litigation risks[3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  3. Hoover Institution - Patent Claims and Patent Scope: https://www.hoover.org/sites/default/files/ip2-wp16001-paper.pdf
  4. FDA - Ranolazine: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/021526Orig1s007.pdf
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,620,814

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,620,814

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1109558 ⤷  Try for Free PA2008017 Lithuania ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free CA 2008 00051 Denmark ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free 91504 Luxembourg ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free PA2008017,C1109558 Lithuania ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free 09C0001 France ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.